This is the authors' abstract. We don't add key points for this paper.
GSD III is a multisystem disorder in which a multidisciplinary approach with regular clinical, biochemical, radiological and functional (physical therapy assessment) follow-up is required. Despite dietary modification, hepatic and myopathic disease progression is evident in adults, with muscle weakness as the major cause of morbidity. Consequently, definitive therapies that address the underlying cause of the disease to correct both liver and muscle are needed.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hijazi et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: